Investigation of Acer Therapeutics, Inc.
Shareholder Class Action Against Acer Therapeutics Inc. (ACER) Survives Motion to Dismiss Acer misrepresented that a conversation it had with the U.S. Food and Drug Administration regarding its drug candidate